Postoperative Pain and Opioid Usage With Combined Adductor Canal and IPACK Block Versus Isolated Adductor Canal Block After Anterior Cruciate Ligament Reconstruction With a Bone–Patellar Tendon–Bone Autograft: A Single-Center Randomized Controlled Trial
Postoperative Schmerzen und Opioidverbrauch mit kombiniertem Adduktorenkanal- und IPACK-Block versus isoliertem Adduktorenkanal-Block nach vorderer Kreuzbandrekonstruktion mit BTB-Autograft: randomisierte kontrollierte Studie an einem Zentrum
The American Journal of Sports Medicine · 2025-05 · 53 (6) · 1359-1367
DOI: 10.1177/03635465251328609 ↗Auf einen Blick
Bei 96 Patient:innen nach ACLR mit BTB-Autograft war die Kombination aus ACB und IPACK mit weniger Opioidverbrauch und teils geringeren Schmerzen verbunden als ACB allein.
Fragestellung
Verbessert die Ergänzung eines IPACK-Blocks zum Adduktorenkanal-Block Schmerz, Opioidbedarf und Zufriedenheit nach ACLR mit BTB-Autograft?
Methode
Randomisierte kontrollierte Studie an einem Zentrum; 102 rekrutierte Patient:innen, 96 in der Endanalyse; Vergleich ACB allein vs. ACB plus IPACK; Nachverfolgung bis 1 Woche.
Ergebnisse
IPACK: weniger Opioide an POD 1, 2 und 3 (z. B. POD 1: 6,1 vs. 10,7 MME; P < .001). Schmerzscore an POD 1 und 3 niedriger, Zufriedenheit an POD 1 höher; an POD 7 kein Unterschied.
Schlussfolgerung der Autor:innen
Die Autoren schließen, dass die Ergänzung eines IPACK-Blocks zum ACB den Opioidverbrauch senkt, die Schmerzkontrolle verbessert und die Zufriedenheit akut nach ACLR mit BTB-Autograft erhöht.
Kernaussagen
- 96 Patient:innen in der Endanalyse
- Weniger Opioidverbrauch unter ACB plus IPACK
- Schmerz und Zufriedenheit teils besser als unter ACB allein
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Klinische Studie (Phase IV) in der Zeitschrift The American Journal of Sports Medicine, online erschienen am 01.05.2025. Verfasst von Naina Rao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedic Surgery, NYU Langone Health, New York, New York, USA. Hauptthemen laut MEDLINE: Analgesics, Opioid, Anterior Cruciate Ligament Reconstruction, Bone-Patellar Tendon-Bone Grafts, Nerve Block. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Background
Efforts to decrease pain, improve early rehabilitation, and reduce opioid consumption have prompted a focus on peripheral nerve blocks for pain management after anterior cruciate ligament reconstruction (ACLR). The commonly used adductor canal block (ACB) might not provide sufficient postoperative pain control because of its lack of coverage of the posterior aspect of the knee. The addition of the IPACK (interspace between the popliteal artery and the capsule of the posterior knee) block, which targets this area, to the standard ACB could potentially provide better pain control after ACLR over the current standard of care. Purpose/Hypothesis: The purpose of this study was to compare and analyze postoperative pain, satisfaction, and opioid demand between the standard ACB and a combination of an ACB and IPACK block in patients undergoing ACLR with a bone–patellar tendon–bone (BTB) autograft. It was hypothesized was that the addition of the IPACK block would substantially improve early postoperative pain control and minimize opioid use. Study Design: Randomized controlled trial; Level of evidence, 2.
Methods
A total of 102 patients undergoing ACLR with a BTB autograft at a single institution were recruited. Patients were randomly assigned to receive either the ACB alone or the ACB plus IPACK block. Patients were contacted at 24 hours (postoperative day [POD] 1), 48 hours (POD 2), 72 hours (POD 3), and 1 week to assess postoperative pain scores, opioid consumption, and satisfaction with their postoperative pain control. Intergroup comparative analysis was performed using a t test or nonparametric test for continuous variables and the chi-square test for categorical variables. Opioid usage was reported as morphine milligram equivalents (MME).
Results
The final analysis included 96 patients, with 47 in the control group (ACB) who received only the ACB and 49 in the experimental group (IPACK) who received the ACB and an additional IPACK block. The cohort was composed of 60.4% male patients with a mean age of 28.40 ± 7.51 years (range, 18-55 years) and a mean body mass index of 25.67 ± 4.84 kg/m 2 . There were no statistically significant differences between the groups with respect to age, body mass index, or sex ( P > .05). Patients in the IPACK group reported significantly lower opioid usage than those in the ACB group on POD 1 (mean, 6.1 [interquartile range (IQR), 4.5-7.7] vs 10.7 [IQR, 8.6-13.0] MME, respectively; P < .001), POD 2 (mean, 7.3 [IQR, 5.2-9.5] vs 12.5 [IQR, 10.0-15.0] MME, respectively; P = .001), and POD 3 (mean, 4.2 [IQR, 2.8-5.5] vs 9.4 [IQR, 7.1-12.0] MME, respectively; P < .001). The visual analog scale for pain score on POD 1 (mean, 67.7 [IQR, 62.0-73.0] vs 55.2 [IQR, 48.0-63.0], respectively; P = .024) and POD 3 (mean, 54.9 [IQR, 48.0-63.0] vs 44.4 [IQR, 37.0-51.0], respectively; P = .037) was statistically higher in the ACB group compared with the IPACK group. On POD 1, patient satisfaction was higher in the IPACK group than in the ACB group (mean, 7.3 [IQR, 6.6-8.0] vs 5.6 [IQR, 4.8-6.4], respectively; P = .001). No statistically significant differences were observed between groups on POD 7. On regression analysis, IPACK block (β = −13.0; P = .03) and male sex (β = −9.9; P = .024) were significant negative predictors for opioid use on POD 1. The association of reduced opioid use in the IPACK group persisted on POD 2 (β = −12.0; P = .019) and POD 3 (β = −15.0; P < .001).
Conclusion
The results of this study suggest that the addition of an IPACK block to an ACB leads to reduced opioid consumption, improved pain control, and higher satisfaction with pain control acutely after ACLR with a BTB autograft. Registration: NCT05286307 (ClinicalTrials.gov)
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedic Surgery, NYU Langone Health, New York, New York, USA.
ORCID-Profile: Naina Rao
Zitieren
APA
Rao, N., Triana, J., Avila, A., Campbell, K. A., Alaia, M. J., Jazrawi, L. M., Furiguele, D., Popovic, J., & Strauss, E. J. (2025). Postoperative Pain and Opioid Usage With Combined Adductor Canal and IPACK Block Versus Isolated Adductor Canal Block After Anterior Cruciate Ligament Reconstruction With a Bone–Patellar Tendon–Bone Autograft: A Single-Center Randomized Controlled Trial. The American Journal of Sports Medicine, 53(6), 1359-1367. https://doi.org/10.1177/03635465251328609
Vancouver
Rao N, Triana J, Avila A, Campbell KA, Alaia MJ, Jazrawi LM, et al. Postoperative Pain and Opioid Usage With Combined Adductor Canal and IPACK Block Versus Isolated Adductor Canal Block After Anterior Cruciate Ligament Reconstruction With a Bone–Patellar Tendon–Bone Autograft: A Single-Center Randomized Controlled Trial. The American Journal of Sports Medicine. 2025;53(6):1359-1367. doi:10.1177/03635465251328609
BibTeX
@article{Rao2025,
author = {Rao, Naina and Triana, Jairo and Avila, Amanda and Campbell, Kirk A and Alaia, Michael J and Jazrawi, Laith M and Furiguele, David and Popovic, Jovan and Strauss, Eric J},
title = {Postoperative Pain and Opioid Usage With Combined Adductor Canal and IPACK Block Versus Isolated Adductor Canal Block After Anterior Cruciate Ligament Reconstruction With a Bone–Patellar Tendon–Bone Autograft: A Single-Center Randomized Controlled Trial},
journal = {The American Journal of Sports Medicine},
year = {2025},
volume = {53},
number = {6},
pages = {1359--1367},
doi = {10.1177/03635465251328609}
}
EUVIMED